Physician profile
Maggi S Smith
NPI 1194768168
$12,162.99
in general payments reported to CMS, 2019-2025
49 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what 92% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $250 · 2021: $2,705 · 2022: $2,922 · 2023: $1,112 · 2024: $2,935 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,017 · Travel and Lodging: $804 · Entertainment: $23.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,016.89 |
| Travel and Lodging | $804.47 |
| Entertainment | $23.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $3,480.18 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $3,133.54 | 2019-2025 | Bun-Yo-Matic, Portfolio, Precision Mis Bunion |
| Stryker Corporation | $1,115.31 | 2020-2025 | Citrefix, Variax, 7 X 23mm Citrelock Implant |
| Smith+Nephew, INC. | $652.52 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Organogenesis INC. | $629.56 | 2019-2025 | Puraply Wound Matrix, Puraply, Apligraf |
| Abbott Laboratories | $325.03 | 2019-2025 | Proclaim |
| Paratek Pharmaceuticals, INC. | $295.88 | 2020-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $228.00 | 2024-2025 | Purified Cortrophin Gel |
| Bioventus LLC | $225.43 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $206.75 | 2024-2025 | |
| Kerecis Limited | $190.22 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $188.32 | 2022-2025 | |
| Nevro Corp. | $133.94 | 2022-2024 | Senza |
| Horizon Therapeutics Plc | $109.79 | 2020-2022 | |
| Mimedx Group, INC. | $101.10 | 2024 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexus Medical Technologies LLC | $95.15 | 2024 | |
| Rock Medical Orthopedics, INC. | $88.30 | 2021-2022 | |
| Boston Scientific Corporation | $81.75 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $77.83 | 2021-2022 | |
| Pfizer INC. | $68.18 | 2019-2020 | |
| Convatec INC. | $58.62 | 2023-2025 | |
| Orthofix Medical, INC. | $52.05 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $50.01 | 2019 | |
| Surgenex LLC | $46.01 | 2025 | Renograft, Surgraft, Surmatrix |
| Pacira Pharmaceuticals Incorporated | $46.00 | 2019-2025 | Exparel |
| Averitas Pharma INC. | $45.09 | 2023-2024 | Qutenza |
| Kci USA, INC. | $38.03 | 2019-2022 | |
| Grt US Holding, INC. | $34.04 | 2021 | |
| Axogen | $25.22 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Hikma Pharmaceuticals USA | $24.09 | 2019-2020 | |
| Access Pro Medical, LLC | $23.86 | 2025 | Matriderm |
| Argentum Medical | $23.10 | 2025 | |
| Fusion Orthopedics USA, LLC | $20.84 | 2025 | |
| Depuy Synthes Sales INC. | $20.72 | 2023 | Fibulink |
| Medtronic, INC. | $20.51 | 2024 | Venaseal |
| Nabriva Therapeutics, Plc | $19.20 | 2022 | |
| Zimmer Biomet Holdings, INC. | $19.12 | 2024 | Nextremity General Instrument, Avitus Bone Harvester, Genex |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.23 | 2025 | Jublia |
| Reprise Biomedical, INC. | $15.66 | 2021 | |
| Heron Therapeutics, INC. | $15.31 | 2021 | |
| Osteomed LLC | $14.78 | 2019 | |
| Melinta Therapeutics, LLC | $14.67 | 2019 | |
| Alafair Biosciences, INC. | $14.37 | 2024 | Versawrap |
| Amgen INC. | $14.34 | 2025 | Krystexxa |
| Acumed LLC | $14.00 | 2023 | Innate Implant, Acumed |
| Medela LLC | $13.31 | 2019 | |
| Tenex Health INC. | $12.13 | 2019 | |
| Alfasigma USA, INC. | $11.71 | 2021 | |
| Assertio Therapeutics, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maggi Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.